Lassman, A., Alexander, B., Berry, D., Berry, N., Buxton, M., Colman, H., … Cloughesy, T. (2024). CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. In Neuro-Oncology (Vol. 26, pp. viii104–viii105). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noae165.0406

Lassman, Andrew, Brian Alexander, Donald Berry, Nicholas Berry, Meredith Buxton, Howard Colman, Hui Gan, et al. “CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.” In Neuro-Oncology, 26:viii104–5. Oxford University Press (OUP), 2024. https://doi.org/10.1093/neuonc/noae165.0406.

Lassman A, Alexander B, Berry D, Berry N, Buxton M, Colman H, et al. CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. In: Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii104–5.

Lassman, Andrew, et al. “CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.” Neuro-Oncology, vol. 26, no. Supplement_8, Oxford University Press (OUP), 2024, pp. viii104–05. Crossref, doi:10.1093/neuonc/noae165.0406.

Lassman A, Alexander B, Berry D, Berry N, Buxton M, Colman H, Gan H, de Groot J, de la Fuente M, Drappatz J, Ducray F, Ellingson B, Gordon G, Hyddmark E, Johnson A, Khasraw M, Lee E, Lim M, McGlothlin A, Mellinghoff I, Mikkelsen T, Nghiemphu P, Perry J, Powell A, Sulman E, Tanner K, Untch S, Weller M, Wen P, Wick A, Yung A, Cloughesy T. CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii104–viii105.